Beruflich Dokumente
Kultur Dokumente
theoretically dubious and practically unnecessary. All such expenditure should be treated as
an expense in the Income Statement and its amount disclosed in notes to the accounts.
Prior to the introduction of the International Financial Reporting Standards (IFRS) in 2001,
all series of standards were a part of the International Accounting Standards (IAS). These are
a set of accounting standards that were published by the International Accounting Standard
Committee (IASC) between 1973 and 2001. They were then developed and supervised by the
The rationale of IAS 38 is to display the appropriate accounting treatment for intangible
assets which are not attended specifically in the IFRS or any other Standard. An intangible
asset is thus defined as an identifiable non-monetary asset without physical substance (IASB,
2014). This Standard obliges an entity to acknowledge an intangible asset if, and only if,
rigorous criteria are met. The Standard then goes further by specifying how to assess the
carrying amount of intangible assets and requires specified disclosures about intangible assets
(IASB, 2014). Within IAS 38, internally generated intangible assets have their own criteria to
meet. Research and Development (R&D), which is at the heart of this essay, is included in
this category. The case of Research is straightforward: given the inherent uncertainty of its
outcome, IAS 38 requires that all Research is to be treated as expenditure. Conversely, the
cases of intangible assets arising from Development, however, are more subjective. As per
the Standard, these shall be recognised if, and only if, six specific requirements are fulfilled,
one including how the intangible asset will generate probable future economic benefits.
Those expenditures on development which fail to meet the six criteria are all written off as
expenses within the income statement (IASB, 2014). In contrast, under Americas accounting
standard, US GAAP, you would expense R&D costs when they are incurred, because the
1
future benefit is not certain and if you can show that the company will receive specific future
benefit from the costs then some R&D costs can be capitalised.
This essay will discuss whether the requirements of IAS 38 in respect of Research and
Development expenditure are theoretically dubious and practically unnecessary and if, as a
result, all such expenditure should be treated as an expense in the Income Statement and its
amount disclosed in notes to the accounts. The essay will consider the affirmative and the
negative, laying out the case for each. It will then weigh the two sides, and come to a
A prominent difficulty that occurs when exploring R&D expenditure is that the deficiencies
to knowledge-based organisations (Lev 2001). The argument put forth by Lev (2001) holds
that disclosure of expenditure is crucial upon adding value to the actual R&D. Lew (2001)
further went on to build an appropriate strategy which could uphold this disclosure, structured
such that it could initiate the revelation process. In his progress to form this strategy, Lev
(2001) utilises the findings of Boone and Raman (2001), who established that within
knowledge-based organisations, large amounts of intangibles consist of high cost capital. Due
to the large amount of intangibles, organisations create a higher bid-ask spread, which
inevitably results in a differentiation between economic worth and reality. This is because
their values consist mainly of intangibles. Nonetheless, R&D is not recognised as an asset in
an organisations balance sheet, leaving its value unheeded. Lev (2001) disputes that under
specified circumstances, if future economic benefits could be derived from R&D expenditure;
the practice of instant expensing within the Income Statement will inevitably lead to biased
2
information which furthers social damage. An example of this is related to cost of capital.
Under the affirmative case, there would be an impediment on investment and growth due to
In their book Corrado, Hulten & Sichel (2005) discuss the impact of R&D investment in
National Income and Product accounts (NIPA). They argue that by treating R&D as
expenditure, rather than an investment, NIPA underestimates R&Ds contribution to the GDP.
The suggestion from their updated article (2009), develops the following identity:
PQ(t)Q(t)=PC(t)C(t)+PI(t)I(t)+PN(t)N(t)=PL(t)L(t)+PK(t)K(t)+PR(t)R(t),
The current national accounts definition of GDP treats intangibles as an intermediate input to
the production of C and I. Here on the other hand, intangible expenditures are treated as
organizational capital etc., are critical investments that sustain a firms market presence in
future years by reducing cost and raising profits beyond the current accounting period (van
Ark et al. 2009). Treating these items as an expense is thus a potentially vital understatement
of both investment (whose signals influence monetary policy decisions), and GDP growth as
a whole.
Furthermore, with increased levels of disclosure, the information asymmetry between the
firm and its vested shareholders and investors naturally subsides, which is directly related to
reducing the agency problem in limited companies. According to Lev (2001), there is little
difference between the balance sheet and the income statement, since the two tend to be
mutually impacting. Lev (2001) also suggests that, despite being important in its role of
3
within the financial statements. This argument is supported by the fact that shares of firms
with more R&D spending tend to perform best against firms with little or no investment into
R&D (Lev 2001). As a result of the current accounting practices, auditors systematically
undervalue intangibles.
On a related note, vital inside information in regards to the progress and succession of a
project is carried within capitalisation. Thus, Lev (2001) argues, a more lenient criterion upon
reliability and control of expenditure should be introduced. With respect to the issue of
recognising clear economic benefits, the auditor could revisit and capitalise past and further
expenditure on the respective project, (Lev, 2005). The introduction of such a criteria would
permit the distribution of credible and relevant information to stakeholders and investors,
reducing the information gap between the company and two parties. The purpose of an
auditor is to comment on whether a companys financial statements are a true and fair
representation (in their view). If more discretion were to be handed to managers in regards to
recognising such intangible assets, an auditors view can be grounded more firmly in facts
and less on professional judgment (Wyatt, 2008). Under IAS 38, R&D can be capitalised via
the accruals principle, where revenue and cost are corresponded. Once commercial
production commences, a stop and start cycle is practiced to amortise the product over its
useful life and subsequently depreciated by the straight-line method. This type of
capitalization will allow for a truer and fairer representation of the company, benefiting the
financial statements. In essence, the concept behind IAS 38 is not theoretically dubious.
On the other hand, the findings of Lev (2001) and Corrado, Hulten & Sichel (2005) fail to
associate their results to the deficiency in the disclosure of R&D expenditure, instead only
demonstrating how they economically diverge. As such, Skinner (2008) claims that these
4
companies with high bid-ask spreads inevitably co-exist with a higher risk. The implication is
It is highly plausible that from conducting a project, initiated through research and
development, there will be no revenue stream due to the high level of uncertainty. What this
means is that R&D expenditures are more vulnerable to legal challenge by the relevant
stakeholders; in essence, their value is state driven (Basu and Waymire, 2008). The shadiness
associated with intangible valuation has been stressed by Basu and Waymire (2008), who
state that valuing accounting intangibles on a stand-alone basis requires heroic assumptions
about seperability, highly uncertain estimates of ambiguous future benefits, and arbitrary
allocations of jointly produced income (Basu and Waymire, 2008). This supports the claim
that R&D expenditure should be entirely expensed as it creates a risk for investors.
Organisations holding intangibles contain larger asymmetries which ultimately lead to a less
liquid market and a higher cost of capital. In the practical sense, there is no clear economic
Moreover, in relation to Levs (2001) concern with the accounting ratios, Basu and Waymire
(2008) began accompanying the inconsistency of market to book ratios to the variation in the
value of non-accounting economic intangibles, which had been displayed through the
deregulation. The appropriate follow-up question is then: where should valuation be derived
from? As per Graham and Meredith (1937), it is the earning power of these intangibles,
rather than their balance sheet valuation, that really counts. The suggestion is that disclosure
of R&D expenditure is unnecessary, since the treatment of R&D is not required for equity
valuation. In other words, contrary to the argument of Lev (2001), there is no need to
5
establish the value of R&D, meaning that, due to the concerns regarding measurability
Again, given that it remains uncertain as to whether these were, in fact, abnormal returns, and
whether there was indeed undervaluation, the rationale behind IAS 38 seems dubious. Indeed,
the market might have correctly reduced these firms expected cash flow, given the riskier
nature of R&D projects (Skinner, 2008). Dedman et al. (2009), contrary to Lev (2001),
concluded that there is little evidence of undervaluation within firms with higher R&D
expenditure. In support of this argument, he demonstrated that the ratio of R&D to market
value is positively associated with the cross-section of average returns (Dedman et al, 2009).
The value of R&D can be questionable at the time they are made, as those expenditures are
This also raises concerns as to whether the auditor will be able operationalize the accrual
principle, since the beneficial cash flow from the R&D is unknown at the time of its
investment. For example, consider the many companies that undergo expensive development
capitalization would allow auditors to go back and undo any accounting decisions. This
ability to change the accounting decisions ex post inevitably gives rise to unreliability and
incorrect manipulation. There also comes the question of management threats; the auditor in
Furthermore, the level of aggregation to apply is very ambiguous. Some firms consider R&D
consisting of many projects. As such, applying prudence may give very different results,
leading to a lack of consistency and comparability across, potentially, firms in the same
6
industry. In this case, the implications in their financial statements would be dependent on
their decisions surrounding aggregation and disclosure of R&D, rather than actual substance.
In addition, numerous companies such as global Tech leader, Google, trade at a larger
premium to their indicated book value, which forms evidence to contradict the notion that
investors solely rely on accounting recognised assets when scrutinizing equity (Penman,
2007). Nixon conducted a survey, questioning organisations accountants and concluded that
accountants believed the expensing of R&D expenditure in the Income Statement had an
negligible impact on companies in terms of the valuation positioned on them, and neither
In conclusion, on the balance of the evidence presented above, it is clear that one must accept
that the requirements of IAS 38 in respect of Research and Development expenditure are
theoretically dubious and practically unnecessary. Whereas the rationales, as well as the
arguments put forth by its proponents, contain good justifications of the Standard, the nature
of R&D is far too uncertain to be applied consistent with prudence. The argument made by
authors such as Lev (2001) focus on the adverse impact that treatment of R&D expenditure as
an expense in the income statement upon managements decisions. However, the rebuttal
from Dedman et. al (2009), stating that the findings are associated more with risk than with
deficiency of procedure, is far more intuitive. The determination of clear economic benefit
is ultimately far too subjective and uncertain. It is compounded by the management threat
arising from auditors then having to correct accounting decisions on behalf of their clients
when capitalised R&D fails to materialise. For these reasons, this essay concludes that the
7
WORD COUNT: 2,033
Bibliography:
Amihud. Y. and Mendelson. H. (1986). 'Asset pricing and the bid-ask spread". Journal of
Basu, S. and Waymire, G. (2008). 'Has the importance of intangibles really grown? And if so,
why?' Accounting and Business Research, 38 (3): 171-190 Special Issue - International
Boone. J.P. and Raman, K.K. (2001). 'Off-balance sheet R&D assets and market liquidity.
Dedman, E., Mouselli, S., Shen, Y. and Stark, A. (2009). Accounting, Intangible Assets, Stock
Market Activity, and Measurement and Disclosure Policy-Views from the U.K. Abacus,
45(3): 312-341.
Graham. B. and Meredith. S. (1937). The Interpretation of Financial Statements. New York,
International Accounting Standards Board (IASB) (2014). IFRS 38 Accounting for Business,
London, IASB.
Lev. B., and Zarowin. P. (1999), 'The boundaries of financial reporting and how to extend
8
Lev, B. (2001). Intangibles: Management. Measurement, and Reporting. Washington, D.C.:
Lev. B., Sarath. B. and Sougiannis, T. (2005). 'R&D reporting biases and their
Oswald, D. (2008). The Determinants and the Value Relevance of the Choice of Accounting
for Research and Development Expenditures in the United Kingdom, Journal of Business
Penman. S.H. (2007). 'Financial reporting quality: is fair value a plus or a minus?"
Accounting and Business Research (Special Issue: International Accounting Policy) Forum:
3344.
Relevant? A Review of the Evidence'. Accounting and Business Research, 38 (3): 217-256.